<DOC>
	<DOC>NCT02961166</DOC>
	<brief_summary>57 patients with Adult Respiratory Distress Syndrome (ARDS) requiring Extracorporeal membrane oxygenation (ECMO) therapy were analyzed retrospectively. 28 patients had received IgM-enriched immunoglobulin therapy (IVIG); 29 patients did not receive IVIG therapy. These patients were analyzed regarding length of stay in intensive care unit (LOS ICU), length of stay (LOS) in hospital and regarding mortality.</brief_summary>
	<brief_title>IgM Enriched Intra Venous Immunoglobulin (IVIG) Therapy in Adult Respiratory Distress Syndrom (ARDS) Patients</brief_title>
	<detailed_description>57 patients with ARDS requiring ECMO therapy were analyzed retrospectively. 28 patients had received IgM-enriched immunoglobulin therapy (IVIG); 29 patients did not receive IVIG therapy. Patient characteristics, like APACHE- and SAPS Score, preexisting diseases, origin of infection, duration of ECMO therapy were analyzed in these patients. These patients were further analyzed regarding LOS ICU, LOS in hospital and regarding mortality.</detailed_description>
	<mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
	<mesh_term>Shock, Septic</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins, Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho(D) Immune Globulin</mesh_term>
	<criteria>All data available ARDS with ECMO therapy Data missing</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>IVIG</keyword>
	<keyword>ARDS</keyword>
	<keyword>ECMO</keyword>
</DOC>